This study was terminated in the United States, in Argentina, in Chile, .... It is testing Seltorexant 20 mg for depression.
DepressionDrugFrom 18 Years to 74 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: September 15, 2020
Recruitment status
Terminated
Enrollment listed in the registry
212
Sponsor
Janssen Research & Development, LLC
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, Argentina, Chile, ...
Age range
From 18 Years to 74 Years
Official registry ID
NCT04532749
Official title
A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
California Neuroscience Research Medical Group, Inc.
Sherman Oaks, California
Site status: Not listed — confirm with the team
Pharmax Research Clinic Inc
Miami, Florida
Site status: Not listed — confirm with the team
Innova Clinical Trials
Miami, Florida
Site status: Not listed — confirm with the team
Harmony Clinical Research Inc
North Miami Beach, Florida
Site status: Not listed — confirm with the team
Medical Research Group of Central Florida
Orange City, Florida
Site status: Not listed — confirm with the team
Synexus Research Orlando
Orlando, Florida
Site status: Not listed — confirm with the team
Stedman Clinical Trials
Tampa, Florida
Site status: Not listed — confirm with the team
Compass Research LLC-Bioclinica Research
The Villages, Florida
Site status: Not listed — confirm with the team
Synexus Clinical Research US Inc
Atlanta, Georgia
Site status: Not listed — confirm with the team
Rush University Medical Center
Chicago, Illinois
Site status: Not listed — confirm with the team
Uptown Research Institute, LLC
Chicago, Illinois
Site status: Not listed — confirm with the team
Phoenix Medical Research, Inc.
Prairie Village, Kansas
Site status: Not listed — confirm with the team
Michigan Clinical Research Institute
Ann Arbor, Michigan
Site status: Not listed — confirm with the team
Eastside Comprehensive Medical Services
New York, New York
Site status: Not listed — confirm with the team
Community Research Management Associates, Inc.
Cincinnati, Ohio
Site status: Not listed — confirm with the team
Patient Priority Clinical Sites LLC
Cincinnati, Ohio
Site status: Not listed — confirm with the team
Intend Research
Norman, Oklahoma
Site status: Not listed — confirm with the team
IPS Research Company
Oklahoma City, Oklahoma
Site status: Not listed — confirm with the team
InSite Clinical Research LLC
DeSoto, Texas
Site status: Not listed — confirm with the team
Pillar Clinical Research, LLC
Richardson, Texas
Site status: Not listed — confirm with the team
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT04532749. We help you review the study, but cannot decide medical eligibility.
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving Seltorexant, Placebo. Phase 3 studies are usually larger and aim to confirm effectiveness and safety in a broader group.
Who might this study be for?
This study may concern people with depression; age range: From 18 Years to 74 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Janssen Research & Development, LLC, which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.